- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A pharmacist alleged an oncology team dinner was purely social. PMCPA found the three-course meal with wine went beyond subsistence and was…
Leo promoted Innohep as “long-term” therapy for VTE in cancer patients. Panel found no breach, but on appeal the Appeal Board ruled…
Pentasa abbreviated ad in a UK conference programme was placed by Swiss global marketing without UK certification. Claims were inconsistent with SPC,…
Ex-employee challenged legibility of prescribing information in BMJ ads for Seroquel XL, Zoladex and Crestor. Panel found Seroquel XL PI not clear…
ProStrakan’s Abstral BMJ ad claimed “Acts in minutes” and “To hell and back in minutes”, implying onset faster than the SPC’s 15…
Resolor promo used “At last! A new way out of chronic constipation in women”. Appeal Board found no breach for folder/drop card…
Lilly’s Diabetes UK “satellite symposium” was ruled promotional, leading to pre-licence promotion findings for exenatide once-weekly (LAR) and misleading exhibition claims about…
Otsuka Europe circulated confusing SPC implementation timelines and certified/distributed incorrect Jinarc prescribing information inconsistent with the SPC. Appeal Board ruled cumulative failings…
Orion-funded respiratory education videos were promoted via an email and hosted on a sponsored academy site. No promotion found, but Orion breached…
GSK was not responsible for a third-party CPD invite using its logo (no breach). But a contractor’s personal LinkedIn share about Bexsero…
Health-professional website page combined a licensed product with pipeline products and implied they were “effective, high quality”. PMCPA ruled pre-licence promotion plus…
PMCPA ruled Lilly’s open-access “patient” section listed diabetes brands/logos with promotional language and no general-public section, amounting to promotion of POMs to…
Former employee alleged inducements to switch to branded products, disguised NHS meetings and over-promotion of Zineryt 90ml. Panel found complainant provided little…
A consultant challenged an Asacol leavepiece claiming “up to 72% treatment success”. Panel found it misleading, but the Appeal Board ruled the…
A GP alleged Novo Nordisk promoted Victoza (liraglutide) for weight loss via Daily Mail coverage. The Panel had concerns about media engagement…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.